Dermapharm Hldg
Stock
Stock
ISIN: DE000A2GS5D8
Ticker: DMP
DE000A2GS5D8
DMP
Price
Price
CHART BY
Historical dividends and forecast
Dermapharm Hldg has so far distributed $0.946 in 2024. The next dividend will be paid on 02.07.2025
$1.165
CHART BY
Frequently asked questions
What is Dermapharm Hldg's market capitalization?
The market capitalization of Dermapharm Hldg is $2.13B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Dermapharm Hldg's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Dermapharm Hldg is 22.59. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Dermapharm Hldg?
Dermapharm Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.755. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Dermapharm Hldg's stock?
Currently, 4 analysts cover Dermapharm Hldg's stock, with a consensus target price of $49.67. Analyst ratings provide insights into the stock's expected performance.
What is Dermapharm Hldg's revenue over the trailing twelve months?
Over the trailing twelve months, Dermapharm Hldg reported a revenue of $1.21B.
What is the EBITDA for Dermapharm Hldg?
Dermapharm Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $318.71M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Dermapharm Hldg?
Dermapharm Hldg has a free cash flow of $113.49M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Dermapharm Hldg's shares?
The free float of Dermapharm Hldg is 16.96M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.13B
- EPS (TTM)
- $1.755
- Free Float
- 16.96M
- P/E ratio (TTM)
- 22.59
- Revenue (TTM)
- $1.21B
- EBITDA (TTM)
- $318.71M
- Free Cashflow (TTM)
- $113.49M
Pricing
- 1D span
- $38.35$39.81
- 52W span
- $32.55$47.74
Analyst Ratings
The price target is $49.67 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- DE000A2GS5D8
- Primary Ticker
- DMP